Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Catabolism of pyrimidines in yeast: A tool to understand degradation of anticancer drugs

In English

Författare

  • Gorm Andersen
  • A. Merico
  • Olof Björnberg
  • Birgit Andersen
  • K. D. Schnackerz
  • D. Dobritzsch
  • Jure Piskur
  • C. Compagno

Summary, in English

The pyrimidine catabolic pathway is of crucial importance in cancer patients because it is involved in degradation of several chemotherapeutic drugs, such as 5-fluorouracil; it also is important in plants, unicellular eukaryotes, and bacteria for the degradation of pyrimidine-based biocides/antibiotics. During the last decade we have developed a yeast species, Saccharomyces kluyveri, as a model and tool to study the genes and enzymes of the pyrimidine catabolic pathway. In this report, we studied degradation of uracil and its putative degradation products in 38 yeasts and showed that this pathway was present in the ancient yeasts but was lost approximately 100 million years ago in the S. cerevisiae lineage.

Publiceringsår

2006

Språk

Engelska

Sidor

991-996

Publikation/Tidskrift/Serie

Nucleosides, Nucleotides & Nucleic Acids

Volym

25

Issue

9-11

Dokumenttyp

Artikel i tidskrift

Förlag

Taylor & Francis

Ämne

  • Biological Sciences

Nyckelord

  • yeast
  • uracil degradation
  • pyrimidines
  • evolution
  • cancer

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 1525-7770